Testosterone Replacement Drug Cases Consolidated
June 12, 2014
On June 6, 2014, the United States Judicial Panel on Multidistrict Litigation (“Panel”) decided to consolidate in the federal court in Chicago about 45 federal testosterone replacement drug cases pending throughout the United States against Abbott Laboratories (“Abbott”) and [...]
Continue Reading
Fungal Meningitis Claims Settled For $100 Million
May 8, 2014
On May 6, 2014, a proposed $100 million settlement was filed in the U.S. Bankruptcy Court in Boston, Massachusetts regarding the claims of 3,300 claimants arising out of the allegedly contaminated steroid injections manufactured by the New England Compounding Center (“NECC”) that was loc[...]
Continue Reading
$850M Vaginal Mesh Settlement Announced
May 2, 2014
On April 30, 2014, Endo International plc (“Endo”), a global specialty healthcare company headquartered in Dublin, Ireland (with its U.S. headquarters located in Malvern, Pennsylvania) that develops, manufactures, markets, and distributes pharmaceutical and device products, announced t[...]
Continue Reading
$14M Yasmin Jury Verdict
April 27, 2014
On April 18, 2014, after a two-week trial, a Cook County, Illinois Circuit Court medical malpractice jury awarded $14 million to a woman who suffered a serious stroke thirteen days after she began taking the birth control medication Yasmin. The 37-year-old woman lost the use of the left side of h[...]
Continue Reading
Arkansas Supreme Court Overturns $1.2B Risperdal Verdict
March 23, 2014
In its written opinion dated March 20, 2014, the Supreme Court of Arkansas (“Arkansas Supreme Court”) overturned a $1.2 billion verdict against Johnson & Johnson (“J & J”) arising out of the alleged improper marketing of its antipsychotic drug, Risperdal. The Arkans[...]
Continue Reading
Accutane Retrial Results In $1.59M Verdict
March 13, 2014
On March 11, 2014, a New Jersey jury awarded $1.59 million (including about $88,000 in past medical expenses) to a woman who developed bowel disease (ulcerative colitis) as a result of using the acne medication, Accutane (isotretinoin), which was manufactured by Switzerland-based Roche Holding AG ([...]
Continue Reading
$4.2M California Settlement For Dietary Supplement Injury
February 19, 2014
A 24-year-old California man recently settled his lawsuit against a dietary supplement distributor for $4,225,000 after he suffered acute liver failure and kidney failure in 2009 after using a dietary supplement. The dietary supplement had been recalled after the FDA expressed its concern that t[...]
Continue Reading
$330.7M Risperdal Verdict In Louisiana Overturned
February 4, 2014
By its written opinion dated January 28, 2014, the Supreme Court of Louisiana (“Louisiana Supreme Court”) reversed (overturned) a lower court’s verdict that had awarded civil penalties in the amount of $257,679,500.00, attorney fees in the amount of $70,000,000.00, and costs [...]
Continue Reading
FDA Issues Testosterone Therapy Safety Alert
February 2, 2014
On January 31, 2014, the FDA issued a Safety Announcement regarding FDA-approved testosterone products. The FDA’s alert concerns the risk of stroke, heart attack, and death in men taking testosterone products that the FDA had previously approved; two recent studies suggest an increased ris[...]
Continue Reading
